Zentiva shares rebound slightly after sharp drop

...three years as a publicly traded company in the previous session.

At 0833 GMT Zentiva shares were up 2.27 percent at 1,219 crowns, clawing back some of Friday's 16.3 percent drop, which was triggered by a statement forecasting weaker-than-expected results.

Zentiva, one of the largest pharmaceutical firms in central Europe, said its profitability would be hurt by price erosion at home, investments in its sales network and one-off costs in its Romanian business.

The company, 25 percent owned by France's Sanofi-Aventis , forecast first-half net income of about 800 million crowns ($39 million), operating profit of around 1.1 billion and net sales of around 6.8 billion.

It had previously forecast a "slightly more than 10 percent" sales growth for this year, suggesting full-year sales of at least 15.4 billion crowns after last year's 14 billion.